SecBot SecBot
8-K ·Filed Mar 3, 2026

SRXH

SRx Health Solutions, Inc.
NEUTRAL
Impact 4/10
Horizonweeks Processed8mo ago SEC0001493152-26-008656
8-K Item 1.01 + 5.02 (likely routine officer/director compensation agreement)
Actionable Insight • Neutral

Monitor for future filings disclosing the terms of the Series B Preferred Stock offering, including size, pricing, and use of proceeds, which could impact equity dilution and company valuation.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$0.1160
T+0 close · Mar 3, 2026 · via day close
Latest settled
+1.72%
T+60 · $0.1180
Vs SPY
−8.59%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Mar 3 $0.1160entry
  2. T+1 · 9mo ago +6.03%α +5.27% · $0.1230
  3. T+5 · 9mo ago +12.93%α +13.41% · $0.1310
  4. T+20 · 8mo ago +11.21%α +15.61% · $0.1290
  5. T+60 · 6mo ago +1.72%α −8.59% · $0.1180
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

SRx Health Solutions obtained waivers from existing investors to proceed with a new preferred stock offering (Series B), allowing the company to issue new securities and waive existing participation rights. The Series B Preferred Stock will rank pari passu with the existing Series A Preferred Stock in terms of dividend and liquidation preferences.

Key Facts

  • SRx Health Solutions entered into limited waiver and consent agreements with existing investors to permit a new securities offering (New Offering).
  • The New Offering involves the issuance of Series B Preferred Stock and related warrants to new accredited investors.
  • Existing investors waived their right of participation in the New Offering and any subsequent placements.
  • Certain existing investors, as Required Holders, consented to the Series B Preferred Stock ranking pari passu with the Series A Preferred Stock regarding dividends, distributions, and liquidation preferences.
  • No financial terms of the New Offering (e.g., size, price, valuation) were disclosed in this filing.

Financial Impact

Potential future capital raise via Series B Preferred Stock offering, but no financial terms disclosed.

equity_structuredilutiondebt

Risk Factors

  • Future dilution to common shareholders upon issuance of Series B Preferred Stock and exercise of related warrants.
  • Potential for unfavorable terms in the New Offering that may not be disclosed until closing.

Market Snapshot

Exchange
NYSE

Investment Themes

Consumer & Retail

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001493152-26-008656
Exhibit: ex10-1.htm0001493152-26-008656
Document: 0001493152-26-008656-index-headers.html0001493152-26-008656
Document: 0001493152-26-008656-index.html0001493152-26-008656
Document: 0001493152-26-008656.txt0001493152-26-008656

Track record

30 reports on SRXH

Performance horizon

4 of 6 bullish or bearish reports moved the stock their way by T+5. Best: +77.11% at T+60 after the Jun 18, 2026 report. 4 of 6 went positive at some point.

Filters
  1. Nov 20, 20261d ago Press Release Neutral 3/10 Entry $0.8402 Now $0.8000 −4.78% settles Nov 30
  2. Nov 20, 20261d ago SC 13D Neutral 5/10 Entry $0.9950 Now $0.8000 −19.60% settles Nov 30
  3. Oct 30, 202622d ago Press Release Neutral 3/10 Entry $1.01 to $0.8116 Now $0.8000 −20.79% ▼ −19.64% −16.94% vs SPY
  4. Oct 7, 20266w ago 8-K Mixed 6/10 Entry $1.49 to $1.29 Now $0.8000 −46.31% ▼ −13.42% −12.44% vs SPY
  5. Oct 6, 20266w ago 8-K Neutral 4/10 Entry $1.49 to $1.29 Now $0.8000 −46.31% ▼ −13.42% −12.44% vs SPY
  6. Sep 24, 20268w ago Press Release Neutral 3/10 Entry $1.73 to $1.61 Now $0.8000 −53.76% ▼ −6.94% −6.52% vs SPY
  7. Sep 9, 202610w ago 8-K Neutral 3/10 Entry $1.51 to $1.60 Now $0.8000 −47.02% ▲ +5.96% +6.62% vs SPY
  8. Sep 2, 202611w ago 8-K Neutral 5/10 Entry $1.56 to $1.59 Now $0.8000 −48.72% ▲ +1.92% +3.07% vs SPY
  9. Aug 28, 202612w ago 8-K Bearish 5/10 Entry $1.68 to $1.59 Now $0.8000 +52.38% ▲ +5.65% +5.51% vs SPY
  10. Aug 19, 202613w ago 8-K Mixed 5/10 Entry $1.87 to $1.84 Now $0.8000 −57.22% ▼ −1.60% −1.22% vs SPY
Showing 10 of 30

US Market Status

Market Closed · Opens Mon (25h 57m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Mar 3, 2026